BG Medicine, Inc. (BGMD) - Product Pipeline Analysis, 2016 Update
Description-
Summary
BG
Medicine,
Inc. (BGM) formerly Beyond Genomics, Inc. is a medical device company
that discovers, develops and delivers diagnostic solutions. The
company offers diagnostics to aid in the clinical management of heart
failure and related disorders. It offers test products which includes
BGM Galectin-3. BGMs BGM Galectin-3 is a diagnostic test, which
measures galectin-3 levels in blood plasma or serum. The companys BGM
Galectin-3 test is available in Europe as an aid in assessing the
prognosis of patients diagnosed with acute and chronic heart failure.
It caters its products to healthcare providers. BGM is headquartered
in Waltham, Massachusetts, the US.
This
report is a source for data, analysis, and actionable intelligence on
the companys portfolio of pipeline products. The report provides key
information about the company, its major products and brands.
The
report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage.
To
Browse a Report Detail with TOC @
http://www.researchmoz.us/bg-medicine-inc-bgmd-product-pipeline-analysis-2016-update-report.html
Scope:
-
The report reviews detailed company profile with information on
business description, key company facts, major products and services,
key competitors, key employees, locations and subsidiaries and recent
developments
-
The report analyzes all pipeline products in development for the
company BG Medicine, Inc.
-
The report provides pipeline analysis on all pipeline products of the
company (by equipment type, by indication, by development stage, and
by trial status)
-
The report covers detailed information on each pipeline product with
information on pipeline territory, stage of development, device
class, regulatory path, indication(s), application(s) and estimated
launch date
-
The report provides detailed description of products in development,
technical specification and functions
-
The report also covers ongoing clinical trials (wherever applicable)
with information on trial name, trial objective, sponsor, trial
design , trial status and phase, estimated start and end date.
Reasons
to Buy:
-
Develop business strategies by understanding the trends and
developments driving the medical devices pipeline and technology
landscape
-
Design and develop your product development, marketing and sales
strategies by understanding the competitor portfolio
-
To formulate effective Research & Development strategies
-
Develop market-entry and market expansion strategies
-
Exploit in-licensing and out-licensing opportunities by identifying
products, most likely to ensure a robust return
-
Plan mergers and acquisitions effectively by identifying key players
of the most promising pipeline
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Develop competition strategies by identifying the status and likely
launch of the competitors pipeline products through review of the
clinical trials, stage and of development, etc
-
Identify, understand and capitalize the next high-value products that
your competitor would add in its portfolio
Table
of Contents
Table
of Contents 2
List
of Tables 4
List
of Figures 5
BG
Medicine, Inc. Company Snapshot 6
BG
Medicine, Inc. Company Overview 6
BG
Medicine, Inc. Pipeline Products and Clinical Trials Overview 7
BG
Medicine, Inc. Pipeline Analysis Overview 9
Key
Facts 9
BG
Medicine, Inc. - Major Products and Services 10
BG
Medicine, Inc. Pipeline Products by Development Stage 11
BG
Medicine, Inc. Pipeline Products Overview 13
BGM
Galectin-3 Test - Adverse Cardiovascular Events 13
BGM
Galectin-3 Test - Adverse Cardiovascular Events Product Overview 13
Biomarkers
- Enbrel Treatment 14
Biomarkers
- Enbrel Treatment Product Overview 14
Biomarkers
- Humira Treatment 15
Biomarkers
- Humira Treatment Product Overview 15
Biomarkers
- Remicade Treatment 16
Biomarkers
- Remicade Treatment Product Overview 16
Diagnostic
Assay - Multiple Sclerosis 17
Diagnostic
Assay - Multiple Sclerosis Product Overview 17
LipidDx
18
LipidDx
Product Overview 18
Molecular
Diagnostic Test For Avandia Treatment 19
Molecular
Diagnostic Test For Avandia Treatment Product Overview 19
BG
Medicine, Inc. - Key Competitors 20
BG
Medicine, Inc. - Key Employees 21
BG
Medicine, Inc. - Locations And Subsidiaries 22
Head
Office 22
Recent
Developments 23
BG
Medicine, Inc., Recent Developments 23
Dec
23, 2015: BG Medicine Withdraws 510(k) Premarket Notification for
Proposed Additional Indication for the BGM Galectin-3 Test 23
Nov
17, 2015: BG Medicine Reports Third Quarter 2015 Financial Results 23
Sep
15, 2015: BG Medicine to Begin Trading on the OTCQB 24
Aug
14, 2015: BG Medicine Reports Second Quarter 2015 Financial Results
24
May
14, 2015: BG Medicine Reports First Quarter 2015 Financial Results 25
Mar
31, 2015: BG Medicine Reports 2014 Fourth Quarter and Year End
Financial Results 26
Mar
31, 2015: BG Medicine Submits 510(k) to FDA for Additional Indication
for the BGM Galectin-3 Test 26
Mar
26, 2015: BG Medicine Welcomes Major Publication on the BioImage
Study in the Journal of the American College of Cardiology 27
Feb
02, 2015: BG Medicine Announces Receipt of Favorable NASDAQ Listing
Determination 27
Nov
20, 2014: BG Medicine, Welcomes Presentation of Clinical Data on
Galectin-3 Testing at the American Heart Association 2014 Scientific
Sessions Conference 28
Appendix
30
Methodology
30
About
GlobalData 30
Contact
Us 30
Disclaimer
30
List
of Tables
BG
Medicine, Inc. Pipeline Products and Clinical Trials Overview 7
BG
Medicine, Inc. Pipeline Products by Equipment Type 7
BG
Medicine, Inc. Pipeline Products by Indication 8
BG
Medicine, Inc., Key Facts 9
BG
Medicine, Inc., Major Products and Services 10
BG
Medicine, Inc. Number of Pipeline Products by Development Stage 11
BG
Medicine, Inc. Pipeline Products Summary by Development Stage 12
BGM
Galectin-3 Test - Adverse Cardiovascular Events - Product Status 13
BGM
Galectin-3 Test - Adverse Cardiovascular Events - Product Description
13
Biomarkers
- Enbrel Treatment - Product Status 14
Biomarkers
- Enbrel Treatment - Product Description 14
Biomarkers
- Humira Treatment - Product Status 15
Biomarkers
- Humira Treatment - Product Description 15
Biomarkers
- Remicade Treatment - Product Status 16
Biomarkers
- Remicade Treatment - Product Description 16
Diagnostic
Assay - Multiple Sclerosis - Product Status 17
Diagnostic
Assay - Multiple Sclerosis - Product Description 17
LipidDx
- Product Status 18
For More Information Kindly Contact:
ResearchMoz Global Pvt. Ltd.
90 State Street,
Albany, NY 12207,
United States
http://www.researchmoz.us,
866-997-4948 (Us-Canada Toll Free),
+1-518-621-2074,
Email to: sales@researchmoz.us,
90 State Street,
Albany, NY 12207,
United States
http://www.researchmoz.us,
866-997-4948 (Us-Canada Toll Free),
+1-518-621-2074,
Email to: sales@researchmoz.us,
Comments
Post a Comment